<?xml version="1.0" encoding="UTF-8"?>
  	<urlset xmlns="http://www.sitemaps.org/schemas/sitemap/0.9" xmlns:news="http://www.google.com/schemas/sitemap-news/0.9"><url>
      <loc>https://www.psychiatrictimes.com/view/treatment-of-repetitive-behaviors-in-autism-where-does-the-evidence-stand</loc>
      <lastmod>2026-11-18T16:00:00Z</lastmod>
      <news:news>
      <news:publication>
        <news:name>Psychiatric Times</news:name>
        <news:language>en</news:language>
      </news:publication>
        <news:publication_date>2026-11-18T16:00:00Z</news:publication_date>
        <news:title><![CDATA[Treatment of Repetitive Behaviors in Autism: Where Does the Evidence Stand?]]></news:title>
      </news:news>
	</url><url>
      <loc>https://www.psychiatrictimes.com/view/why-depression-subtypes-matter-lessons-from-25-years-in-the-clinic</loc>
      <lastmod>2026-11-18T15:00:00Z</lastmod>
      <news:news>
      <news:publication>
        <news:name>Psychiatric Times</news:name>
        <news:language>en</news:language>
      </news:publication>
        <news:publication_date>2026-11-18T15:00:00Z</news:publication_date>
        <news:title><![CDATA[Why Depression Subtypes Matter: Lessons From 25 Years in the Clinic]]></news:title>
      </news:news>
	</url><url>
      <loc>https://www.psychiatrictimes.com/view/2027-plans-for-opti-101-phase-2b-in-major-depressive-disorder-and-opti-201-phase-3-in-ptsd</loc>
      <lastmod>2026-11-18T14:17:31.045Z</lastmod>
      <news:news>
      <news:publication>
        <news:name>Psychiatric Times</news:name>
        <news:language>en</news:language>
      </news:publication>
        <news:publication_date>2026-11-18T14:17:31.045Z</news:publication_date>
        <news:title><![CDATA[2027 Plans for OPTI-101 Phase 2b in Major Depressive Disorder and OPTI-201 Phase 3 in PTSD]]></news:title>
      </news:news>
	</url><url>
      <loc>https://www.psychiatrictimes.com/view/rapid-acting-antidepressants-and-the-psychedelics-debate</loc>
      <lastmod>2026-11-18T13:05:00Z</lastmod>
      <news:news>
      <news:publication>
        <news:name>Psychiatric Times</news:name>
        <news:language>en</news:language>
      </news:publication>
        <news:publication_date>2026-11-18T13:05:00Z</news:publication_date>
        <news:title><![CDATA[Rapid-Acting Antidepressants and the Psychedelics Debate]]></news:title>
      </news:news>
	</url><url>
      <loc>https://www.psychiatrictimes.com/view/starting-with-the-non-negotiables-selecting-adjunctive-therapy-in-mdd</loc>
      <lastmod>2026-11-18T13:00:00Z</lastmod>
      <news:news>
      <news:publication>
        <news:name>Psychiatric Times</news:name>
        <news:language>en</news:language>
      </news:publication>
        <news:publication_date>2026-11-18T13:00:00Z</news:publication_date>
        <news:title><![CDATA[Starting With the Non-Negotiables: Selecting Adjunctive Therapy in MDD]]></news:title>
      </news:news>
	</url><url>
      <loc>https://www.psychiatrictimes.com/view/phase-3-data-back-tau-pet-agent-florquinitau-f-18-for-detecting-neurofibrillary-tangles-in-alzheimer-disease</loc>
      <lastmod>2026-11-17T18:13:01.109Z</lastmod>
      <news:news>
      <news:publication>
        <news:name>Psychiatric Times</news:name>
        <news:language>en</news:language>
      </news:publication>
        <news:publication_date>2026-11-17T18:13:01.109Z</news:publication_date>
        <news:title><![CDATA[Phase 3 Data Back Tau PET Agent Florquinitau F 18 for Detecting Neurofibrillary Tangles in Alzheimer Disease]]></news:title>
      </news:news>
	</url><url>
      <loc>https://www.psychiatrictimes.com/view/mixed-results-from-phase-3-data-for-ar1001-in-alzheimer-disease</loc>
      <lastmod>2026-11-17T17:47:37.512Z</lastmod>
      <news:news>
      <news:publication>
        <news:name>Psychiatric Times</news:name>
        <news:language>en</news:language>
      </news:publication>
        <news:publication_date>2026-11-17T17:47:37.512Z</news:publication_date>
        <news:title><![CDATA[Mixed Results From Phase 3 Data for AR1001 in Alzheimer Disease]]></news:title>
      </news:news>
	</url><url>
      <loc>https://www.psychiatrictimes.com/view/psyched-perspectives-social-determinants-of-health-in-women-economic-structure-burnout-and-connection</loc>
      <lastmod>2026-11-17T16:00:00Z</lastmod>
      <news:news>
      <news:publication>
        <news:name>Psychiatric Times</news:name>
        <news:language>en</news:language>
      </news:publication>
        <news:publication_date>2026-11-17T16:00:00Z</news:publication_date>
        <news:title><![CDATA[Psyched Perspectives: Social Determinants of Health in Women: Economic Structure, Burnout, and Connection]]></news:title>
      </news:news>
	</url><url>
      <loc>https://www.psychiatrictimes.com/view/ketamine-for-treatment-resistant-depression-practical-clinical-considerations</loc>
      <lastmod>2026-11-17T15:00:00Z</lastmod>
      <news:news>
      <news:publication>
        <news:name>Psychiatric Times</news:name>
        <news:language>en</news:language>
      </news:publication>
        <news:publication_date>2026-11-17T15:00:00Z</news:publication_date>
        <news:title><![CDATA[Ketamine for Treatment-Resistant Depression: Practical Clinical Considerations]]></news:title>
      </news:news>
	</url></urlset>